 | • レポートコード：GIR-107A13586 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、呼吸用吸入器のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。呼吸用吸入器の種類別市場規模（乾式粉末吸入器、定量吸入器、ネブライザー）、用途別市場規模（喘息、COPD、肺動脈性肺高血圧症、その他呼）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・呼吸用吸入器の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Beximco Pharmaceuticals Ltd.、Boehringer Ingelheim GmbH、Cipla Ltd.、GlaxoSmithKline plc、Koninklijke Philips N.V.、Merck & Co., Inc.、OMRON Healthcare Europe B.V.、PARI Medical Holding、Teva Pharmaceutical Industries Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：乾式粉末吸入器、定量吸入器、ネブライザー ・用途別分析2016年-2026年：喘息、COPD、肺動脈性肺高血圧症、その他呼 ・呼吸用吸入器の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・呼吸用吸入器のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・呼吸用吸入器のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・呼吸用吸入器の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・呼吸用吸入器の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Respiratory Inhaler Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Respiratory Inhaler Devices size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Respiratory Inhaler Devices market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Respiratory Inhaler Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Market segment by Application can be divided into
Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease
The key market players for global Respiratory Inhaler Devices market are listed below:
AstraZeneca
Beximco Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Cipla Ltd.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Merck & Co., Inc.
OMRON Healthcare Europe B.V.
PARI Medical Holding
Teva Pharmaceutical Industries Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Respiratory Inhaler Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Respiratory Inhaler Devices, with price, sales, revenue and global market share of Respiratory Inhaler Devices from 2019 to 2021.
Chapter 3, the Respiratory Inhaler Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Respiratory Inhaler Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Respiratory Inhaler Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Respiratory Inhaler Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Respiratory Inhaler Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Respiratory Inhaler Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Nebulizer
1.3 Market Analysis by Application
1.3.1 Overview: Global Respiratory Inhaler Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Asthma
1.3.3 COPD
1.3.4 Pulmonary Arterial Hypertension
1.3.5 Others Respiratory Disease
1.4 Global Respiratory Inhaler Devices Market Size & Forecast
1.4.1 Global Respiratory Inhaler Devices Sales in Value (2016-2026))
1.4.2 Global Respiratory Inhaler Devices Sales in Volume (2016-2026)
1.4.3 Global Respiratory Inhaler Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Respiratory Inhaler Devices Production Capacity Analysis
1.5.1 Global Respiratory Inhaler Devices Total Production Capacity (2016-2026)
1.5.2 Global Respiratory Inhaler Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Respiratory Inhaler Devices Market Drivers
1.6.2 Respiratory Inhaler Devices Market Restraints
1.6.3 Respiratory Inhaler Devices Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Respiratory Inhaler Devices Product and Services
2.1.4 AstraZeneca Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Beximco Pharmaceuticals Ltd.
2.2.1 Beximco Pharmaceuticals Ltd. Details
2.2.2 Beximco Pharmaceuticals Ltd. Major Business
2.2.3 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Product and Services
2.2.4 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Product and Services
2.3.4 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cipla Ltd.
2.4.1 Cipla Ltd. Details
2.4.2 Cipla Ltd. Major Business
2.4.3 Cipla Ltd. Respiratory Inhaler Devices Product and Services
2.4.4 Cipla Ltd. Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business
2.5.3 GlaxoSmithKline plc Respiratory Inhaler Devices Product and Services
2.5.4 GlaxoSmithKline plc Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Koninklijke Philips N.V.
2.6.1 Koninklijke Philips N.V. Details
2.6.2 Koninklijke Philips N.V. Major Business
2.6.3 Koninklijke Philips N.V. Respiratory Inhaler Devices Product and Services
2.6.4 Koninklijke Philips N.V. Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business
2.7.3 Merck & Co., Inc. Respiratory Inhaler Devices Product and Services
2.7.4 Merck & Co., Inc. Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 OMRON Healthcare Europe B.V.
2.8.1 OMRON Healthcare Europe B.V. Details
2.8.2 OMRON Healthcare Europe B.V. Major Business
2.8.3 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Product and Services
2.8.4 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 PARI Medical Holding
2.9.1 PARI Medical Holding Details
2.9.2 PARI Medical Holding Major Business
2.9.3 PARI Medical Holding Respiratory Inhaler Devices Product and Services
2.9.4 PARI Medical Holding Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Teva Pharmaceutical Industries Ltd
2.10.1 Teva Pharmaceutical Industries Ltd Details
2.10.2 Teva Pharmaceutical Industries Ltd Major Business
2.10.3 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Product and Services
2.10.4 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Respiratory Inhaler Devices Sales by Manufacturer
3.1 Global Respiratory Inhaler Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Respiratory Inhaler Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Respiratory Inhaler Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Respiratory Inhaler Devices Manufacturer Market Share
3.4.2 Top 6 Respiratory Inhaler Devices Manufacturer Market Share
3.5 Global Respiratory Inhaler Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Respiratory Inhaler Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Respiratory Inhaler Devices Market Size by Region
4.1.1 Global Respiratory Inhaler Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Respiratory Inhaler Devices Revenue by Region (2016-2026)
4.2 North America Respiratory Inhaler Devices Revenue (2016-2026)
4.3 Europe Respiratory Inhaler Devices Revenue (2016-2026)
4.4 Asia-Pacific Respiratory Inhaler Devices Revenue (2016-2026)
4.5 South America Respiratory Inhaler Devices Revenue (2016-2026)
4.6 Middle East and Africa Respiratory Inhaler Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Respiratory Inhaler Devices Sales in Volume by Type (2016-2026)
5.2 Global Respiratory Inhaler Devices Revenue by Type (2016-2026)
5.3 Global Respiratory Inhaler Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Respiratory Inhaler Devices Sales in Volume by Application (2016-2026)
6.2 Global Respiratory Inhaler Devices Revenue by Application (2016-2026)
6.3 Global Respiratory Inhaler Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Respiratory Inhaler Devices Sales by Type (2016-2026)
7.2 North America Respiratory Inhaler Devices Sales by Application (2016-2026)
7.3 North America Respiratory Inhaler Devices Market Size by Country
7.3.1 North America Respiratory Inhaler Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Respiratory Inhaler Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Respiratory Inhaler Devices Sales by Type (2016-2026)
8.2 Europe Respiratory Inhaler Devices Sales by Application (2016-2026)
8.3 Europe Respiratory Inhaler Devices Market Size by Country
8.3.1 Europe Respiratory Inhaler Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Respiratory Inhaler Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Respiratory Inhaler Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Respiratory Inhaler Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Respiratory Inhaler Devices Market Size by Region
9.3.1 Asia-Pacific Respiratory Inhaler Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Respiratory Inhaler Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Respiratory Inhaler Devices Sales by Type (2016-2026)
10.2 South America Respiratory Inhaler Devices Sales by Application (2016-2026)
10.3 South America Respiratory Inhaler Devices Market Size by Country
10.3.1 South America Respiratory Inhaler Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Respiratory Inhaler Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Respiratory Inhaler Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Respiratory Inhaler Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Respiratory Inhaler Devices Market Size by Country
11.3.1 Middle East & Africa Respiratory Inhaler Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Respiratory Inhaler Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Respiratory Inhaler Devices Typical Distributors
12.3 Respiratory Inhaler Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Respiratory Inhaler Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Respiratory Inhaler Devices Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Respiratory Inhaler Devices Product and Services
Table 6. AstraZeneca Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Beximco Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Beximco Pharmaceuticals Ltd. Major Business
Table 9. Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Product and Services
Table 10. Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim GmbH Major Business
Table 13. Boehringer Ingelheim GmbH Respiratory Inhaler Devices Product and Services
Table 14. Boehringer Ingelheim GmbH Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Cipla Ltd. Major Business
Table 17. Cipla Ltd. Respiratory Inhaler Devices Product and Services
Table 18. Cipla Ltd. Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline plc Major Business
Table 21. GlaxoSmithKline plc Respiratory Inhaler Devices Product and Services
Table 22. GlaxoSmithKline plc Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Koninklijke Philips N.V. Basic Information, Manufacturing Base and Competitors
Table 24. Koninklijke Philips N.V. Major Business
Table 25. Koninklijke Philips N.V. Respiratory Inhaler Devices Product and Services
Table 26. Koninklijke Philips N.V. Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co., Inc. Major Business
Table 29. Merck & Co., Inc. Respiratory Inhaler Devices Product and Services
Table 30. Merck & Co., Inc. Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. OMRON Healthcare Europe B.V. Basic Information, Manufacturing Base and Competitors
Table 32. OMRON Healthcare Europe B.V. Major Business
Table 33. OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Product and Services
Table 34. OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PARI Medical Holding Basic Information, Manufacturing Base and Competitors
Table 36. PARI Medical Holding Major Business
Table 37. PARI Medical Holding Respiratory Inhaler Devices Product and Services
Table 38. PARI Medical Holding Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Ltd Major Business
Table 41. Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Product and Services
Table 42. Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Respiratory Inhaler Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Respiratory Inhaler Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Respiratory Inhaler Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Respiratory Inhaler Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Respiratory Inhaler Devices Production Site of Key Manufacturer
Table 48. Respiratory Inhaler Devices New Entrant and Capacity Expansion Plans
Table 49. Respiratory Inhaler Devices Mergers & Acquisitions in the Past Five Years
Table 50. Global Respiratory Inhaler Devices Sales by Region (2016-2021e) & (K Units)
Table 51. Global Respiratory Inhaler Devices Sales by Region (2021-2026) & (K Units)
Table 52. Global Respiratory Inhaler Devices Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Respiratory Inhaler Devices Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 55. Global Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 56. Global Respiratory Inhaler Devices Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Respiratory Inhaler Devices Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Respiratory Inhaler Devices Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Respiratory Inhaler Devices Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 61. Global Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 62. Global Respiratory Inhaler Devices Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Respiratory Inhaler Devices Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Respiratory Inhaler Devices Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Respiratory Inhaler Devices Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Respiratory Inhaler Devices Sales by Country (2016-2021e) & (K Units)
Table 67. North America Respiratory Inhaler Devices Sales by Country (2021-2026) & (K Units)
Table 68. North America Respiratory Inhaler Devices Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Respiratory Inhaler Devices Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 71. North America Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 72. North America Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 73. North America Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 74. Europe Respiratory Inhaler Devices Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Respiratory Inhaler Devices Sales by Country (2021-2026) & (K Units)
Table 76. Europe Respiratory Inhaler Devices Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Respiratory Inhaler Devices Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 80. Europe Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Respiratory Inhaler Devices Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Respiratory Inhaler Devices Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Respiratory Inhaler Devices Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Respiratory Inhaler Devices Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 90. South America Respiratory Inhaler Devices Sales by Country (2016-2021e) & (K Units)
Table 91. South America Respiratory Inhaler Devices Sales by Country (2021-2026) & (K Units)
Table 92. South America Respiratory Inhaler Devices Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Respiratory Inhaler Devices Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 95. South America Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 96. South America Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 97. South America Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Respiratory Inhaler Devices Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Respiratory Inhaler Devices Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Respiratory Inhaler Devices Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Respiratory Inhaler Devices Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Respiratory Inhaler Devices Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Respiratory Inhaler Devices Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Respiratory Inhaler Devices Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Respiratory Inhaler Devices Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Respiratory Inhaler Devices Typical Distributors
Table 109. Respiratory Inhaler Devices Typical Customers
List of Figures
Figure 1. Respiratory Inhaler Devices Picture
Figure 2. Global Respiratory Inhaler Devices Sales Market Share by Type in 2020
Figure 3. Dry Powder Inhaler
Figure 4. Metered Dose Inhaler
Figure 5. Nebulizer
Figure 6. Global Respiratory Inhaler Devices Sales Market Share by Application in 2020
Figure 7. Asthma
Figure 8. COPD
Figure 9. Pulmonary Arterial Hypertension
Figure 10. Others Respiratory Disease
Figure 11. Global Respiratory Inhaler Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Respiratory Inhaler Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Respiratory Inhaler Devices Sales (2016-2026) & (K Units)
Figure 14. Global Respiratory Inhaler Devices Price by Type (2016-2026) & (USD/Unit)
Figure 15. Global Respiratory Inhaler Devices Production Capacity (2016-2026) & (K Units)
Figure 16. Global Respiratory Inhaler Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Respiratory Inhaler Devices Market Drivers
Figure 18. Respiratory Inhaler Devices Market Restraints
Figure 19. Respiratory Inhaler Devices Market Trends
Figure 20. Global Respiratory Inhaler Devices Sales Market Share by Manufacturer in 2020
Figure 21. Global Respiratory Inhaler Devices Revenue Market Share by Manufacturer in 2020
Figure 22. Respiratory Inhaler Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Respiratory Inhaler Devices Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Respiratory Inhaler Devices Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Respiratory Inhaler Devices Sales Market Share by Region (2016-2026)
Figure 26. Global Respiratory Inhaler Devices Revenue Market Share by Region (2016-2026)
Figure 27. North America Respiratory Inhaler Devices Revenue (2016-2026) & (USD Million)
Figure 28. Europe Respiratory Inhaler Devices Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Respiratory Inhaler Devices Revenue (2016-2026) & (USD Million)
Figure 30. South America Respiratory Inhaler Devices Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Respiratory Inhaler Devices Revenue (2016-2026) & (USD Million)
Figure 32. Global Respiratory Inhaler Devices Sales Market Share by Type (2016-2026)
Figure 33. Global Respiratory Inhaler Devices Revenue Market Share by Type (2016-2026)
Figure 34. Global Respiratory Inhaler Devices Price by Type (2016-2026) & (USD/Unit)
Figure 35. Global Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 36. Global Respiratory Inhaler Devices Revenue Market Share by Application (2016-2026)
Figure 37. Global Respiratory Inhaler Devices Price by Application (2016-2026) & (USD/Unit)
Figure 38. North America Respiratory Inhaler Devices Sales Market Share by Type (2016-2026)
Figure 39. North America Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 40. North America Respiratory Inhaler Devices Sales Market Share by Country (2016-2026)
Figure 41. North America Respiratory Inhaler Devices Revenue Market Share by Country (2016-2026)
Figure 42. United States Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Respiratory Inhaler Devices Sales Market Share by Type (2016-2026)
Figure 46. Europe Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 47. Europe Respiratory Inhaler Devices Sales Market Share by Country (2016-2026)
Figure 48. Europe Respiratory Inhaler Devices Revenue Market Share by Country (2016-2026)
Figure 49. Germany Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Respiratory Inhaler Devices Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Respiratory Inhaler Devices Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Respiratory Inhaler Devices Revenue Market Share by Region (2016-2026)
Figure 58. China Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Respiratory Inhaler Devices Sales Market Share by Type (2016-2026)
Figure 65. South America Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Respiratory Inhaler Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Respiratory Inhaler Devices Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Respiratory Inhaler Devices Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Respiratory Inhaler Devices Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Respiratory Inhaler Devices Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Respiratory Inhaler Devices Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Respiratory Inhaler Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界のCOPDおよび喘息治療薬市場予測（～2024年） Scope of the Report: The worldwide market for COPD and Asthma Drug Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the COPD and A…- ソフトミスト製剤（レスピマット、SMI）市場：世界及び中国市場分析・予測（～2024年） Soft Mist Inhaler (Respimat,SMI) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Soft Mist Inhaler (Respimat,SMI) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Soft…
- 世界のブデソニド吸入器市場予測（～2024年） Budesonide Inhaler is a corticosteroid used treat a range of breathing conditions including asthma. Corticosteroids work because they reduce swelling and irritation in the airways, making air flow easier in the lungs. Scope of the Report: The worldwide market for Budesonide Inhaler is expected to gr…
- 世界の呼吸器診断装置市場 2021：企業別、地域別、種類・用途別 The Respiratory Diagnostic Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の呼吸装置市場 2021：企業別、地域別、種類・用途別 The Respiratory Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…